Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.

Source:http://linkedlifedata.com/resource/pubmed/id/17010047

Download in:

View as

General Info

PMID
17010047